Compare Shell PLC (SHEL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Zimmer Biomet Holdings Inc — how do they compare? Shell PLC trades at $86.69 (market cap $235.24B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Shell PLC is far larger — about 13.6× Zimmer Biomet Holdings Inc's market cap, and Shell PLC pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| SHEL | ZBH | |
|---|---|---|
Market Cap | $235.24B | $17.36B |
Sector | Energy | Health |
52-Week High | $94.15 | $107.71 |
52-Week Low | $70.31 | $79.58 |
Enterprise Value | $287.77B | $24.40B |
Dividend Yield | 3.63% | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
